Health Canada - Drug and Medical Device Recall Listings - (December 28, 2011): This section has been designed to... http://t.co/P2jIZ304
Thursday, 23 February 2012
The requested URL was not found on this server.What is drug Safety?
A video introduction from Uppsala Monitoring Center
Health Canada - Drug and Medical Device Recall Listings - (December 28, 2011): This section has been designed to... http://t.co/P2jIZ304
Health Canada - Consultation: Cleaning Validation Guidance (GUI-0028): Three month consultation of Cleaning... http://t.co/LAYXbRMr
Health Canada - Consultation Draft Guidance on Process Validation: Terminal Sterilization Processes for... http://t.co/0iapwwGF
Health Canada - Cells, Tissues and Organs: Developing a model for scheduling Cells, Tissues and Organs Inspection -... http://t.co/2B0386NK
Health Canada - Consultation: Draft Guidance on Classification of Observations for Inspection of Cells, Tissues and... http://t.co/ciBRW0yX
Health Canada - List of Canadian Establishments that Proces and/or Import Semen for Assisted Conception: The... http://t.co/zWtT9ekW
Health Canada - Consultation: Draft Guidance on Good Manufacturing Practices (GMP) for Medical Devices (GUI-0031):... http://t.co/frAEIL69
Health Canada - Medical Devices: Reviewing the Medical Devices Inspection: Health Canada is in the process of... http://t.co/KMk6nSLv
Health Canada - Inspection Strategy for Medical Device Companies (POL-0035): The purpose of this document is to... http://t.co/mXhP4hj0
DMA- Danish translation of the PhVWP's recommendation for the product information of escitalopram: The European... http://t.co/A9fr7DZ4
FDA- Comunicado de la FDA sobre la seguridad de los medicamentos: Importantes interacciones entre el medicamento... http://t.co/nhorfQf0
FDA- January 2012: Monthly Safety Labeling Changes includes 63 products with revisions to Prescribing Information. http://t.co/4dRKTPU9
FDA- Comunicado de la FDA sobre la seguridad de los medicamentos: La diarrea asociada con Clostridum difficile puede... http://t.co/wsmdVqdC
DMA- Changed criteria for single reimbursement for osteoporosis medicines other than alendronate: Conditional... http://t.co/vQokSOUs
DMA- Decision on general conditional reimbursement for alendronate-containing medicines: Conditional reimbursement... http://t.co/5pHiYXpP
© 2011 Ottosen. All rights reserved.
All site content is provided "as is" and does not represent the views of any organization
